"The United States has moved to reclassify marijuana as a less dangerous drug in a historic shift that has sent shares in cannabisfirms soaring.
The US Justice Department’s recommendation on Tuesday that cannabis be classified as a schedule three drug – the same as ketamine and Tylenol with codeine – does not legalize recreational use outright but opens the way to lighter punishments as well as greater private investment tax benefits for the industry.
Shares of Canada’s Canopy Growth Corporation and Cronos Group surged 80.02 percent and 15.71 percent, respectively, while US-based Cronos Group jumped nearly 40 percent."
AlJazeera